#Coronavirus Disease Research #References (AMEDEO, Oct. 3 '26)

 

Emerg Infect Dis

1. BHUIYA S, Shuvo TA, Hassan MZ, Aleem MA, et al
   The Impermanence of Public Health Gains-Lessons Learned from Measles Resurgence, Bangladesh, 2026.
   Emerg Infect Dis. 2026;32.
   PubMed         Abstract available
   
   
2. MADDEN EF, Ellis SL, Parisi A, Selvey CE, et al
   Age Differences in Pertussis Epidemics, New South Wales, Australia, 2015 and 2024.
   Emerg Infect Dis. 2026;32:1759-1762.
   PubMed         Abstract available
   
   

   
   Graefes Arch Clin Exp Ophthalmol

3. ZONTAG N, Wygnanski-Jaffe T, Bahir D, Ben-Zion I, et al
   Impact of COVID-19 on refractive amblyopia risk factors in 5-years-old children: A nationwide cross sectional study.
   Graefes Arch Clin Exp Ophthalmol. 2026 Sep 26. doi: 10.1007/s00417-026-07511.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

4. KAGUJJE M, Kerkhoff AD, Maimbolwa M, Sanjase N, et al
   Clinically diagnosed pulmonary TB and its association with mortality in Zambia: a secondary data analysis of a prospective diagnostic cohort.
   Int J Infect Dis. 2026 Sep 30:109141. doi: 10.1016/j.ijid.2026.109141.
   PubMed         Abstract available
   
   
5. GUDINA EK, Abera EG, Ali S, Maleko WA, et al
   Respiratory viral and bacterial pathogen dynamics among healthcare workers and community members in Ethiopia: A prospective cohort study.
   Int J Infect Dis. 2026 Sep 30:109157. doi: 10.1016/j.ijid.2026.109157.
   PubMed         Abstract available
   
   
6. EINARSDOTTIR S, Fei T, Sotelo-Alva MI, Gomez-Llobell M, et al
   Respiratory Viral Infections Following CAR-T Cell Therapy for Lymphoma and Myeloma: Severity and Immune Correlates.
   Int J Infect Dis. 2026 Sep 27:109138. doi: 10.1016/j.ijid.2026.109138.
   PubMed         Abstract available
   
   
7. NAKAJO K, Miyama T, Nagata M, Ko YK, et al
   Resurgence of measles in Japan, a highly vaccinated country: a risk assessment study.
   Int J Infect Dis. 2026 Sep 26:109143. doi: 10.1016/j.ijid.2026.109143.
   PubMed         Abstract available
   
   

   
   J Infect

8. NAZARETH J, Martin CA, Pan D, Barr IG, et al
   Ethnic differences in inactivated influenza vaccine immunogenicity in UK Healthcare Workers: A two-year prospective longitudinal study.
   J Infect. 2026 Sep 29:106862. doi: 10.1016/j.jinf.2026.106862.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. FREITAS NL, Gomes YCP, Nogueira FCS, Echevarria-Lima J, et al
   Acute Neurological Manifestations in COVID-19 Are Associated With Complement Activation and Glia-Promoted Neuroinflammation.
   J Med Virol. 2026;98:e71165.
   PubMed         Abstract available
   
   

   
   J Virol

10. ALI MS, O'Brien A, Qing E, Sarkar L, et al
    A chimeric murine coronavirus with altered deISGylase and proteolytic activities exhibits attenuated viral pathogenesis.
    J Virol. 2026 Sep 30:e0085726. doi: 10.1128/jvi.00857.
    PubMed         Abstract available
    
    
11. ZHANG N, Xu Y, Chen Y, Ma M, et al
    DEAD-box RNA helicase 21 interacts with the nucleocapsid protein and inhibits porcine deltacoronavirus infection through upregulation of interferon responses.
    J Virol. 2026 Sep 30:e0116926. doi: 10.1128/jvi.01169.
    PubMed         Abstract available
    
    
12. SUN M, Yuan C, Duan Y, Shi L, et al
    GSK3 maintains NSP12 stability to promote bat-origin swine acute diarrhea syndrome coronavirus infection.
    J Virol. 2026 Sep 30:e0068326. doi: 10.1128/jvi.00683.
    PubMed         Abstract available
    
    
13. ZENG M, Liu D, Zhang J, Zhang L, et al
    MOV10 inhibits SADS-CoV replication by enhancing TRIM24-mediated K63-linked TRAF3 ubiquitination, and this inhibition is antagonized by viral N protein.
    J Virol. 2026 Sep 29:e0121526. doi: 10.1128/jvi.01215.
    PubMed         Abstract available
    
    

    
    Radiology

14. KIM N
    A 5-year Follow-up on the Persistence of Post-COVID-19 Lung Injury.
    Radiology. 2026;320:e262429.
    PubMed